(Q51869405)

14 April 2018

title

Health-related quality of life in patients with different stages of liver disease induced by hepatitis C. (English)

1 reference

14 April 2018

1 reference

Einar Björnsson

1

1 reference

14 April 2018

Hans Verbaan

2

1 reference

14 April 2018

Antti Oksanen

3

1 reference

14 April 2018

Aril Frydén

4

1 reference

14 April 2018

Jonas Johansson

5

1 reference

14 April 2018

Sarah Friberg

6

1 reference

14 April 2018

Olav Dalgård

7

1 reference

14 April 2018

Evangelos Kalaitzakis

8

1 reference

14 April 2018

publication date

1 January 2009

1 reference

14 April 2018

Scandinavian Journal of Gastroenterology

published in

1 reference

14 April 2018

volume

44

1 reference

14 April 2018

issue

7

1 reference

14 April 2018

page(s)

878-887

1 reference

14 April 2018

The natural history of chronic hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

The effects of HCV infection and management on health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

"They treated me like a leper". Stigmatization and the quality of life of patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Variations in population health status: results from a United Kingdom national questionnaire survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Deteriorating health status in Stockholm 1998-2002: results from repeated population surveys using the EQ-5D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Factors associated with poor health-related quality of life of patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Fatigue is not a specific symptom in patients with primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Determinants of health-related quality of life in patients with chronic liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Comparing the safety, tolerability and quality of life in patients with chronic hepatitis B vs chronic hepatitis C treated with peginterferon alpha-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

Health-State Utilities and Quality of Life in Hepatitis C Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520902898135

10.1080/00365520902898135

21 January 2018

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018